HomeMerck SeronoContact UsGlossaryReferencesSearchSite Guide

 Concern MenuConcern
 Treatment MenuTreatment
 Pregnancy MenuPregnancy
 Experiences MenuExperiences

Treatment

  The Doctor's Visit
  Personalised Treatment
  Female Treatments
  First Step
  Second Step
  Follicle-stimulating Hormone
  Human Menopausal Gonadotropin
  Human Chorionic Gonadotropin
  Gonadotropin-releasing Hormone
  Luteinising Hormone
  Third Step
  Male Treatments
  Implications of Treatment
  Enhance Your Well-being
  Questions to Ask Your Doctor
  Treatment FAQ
  Devices for Administration of Medication
graphic

Luteinising Hormone

Together with follicle stimulating hormone (FSH), Luteinising Hormone (LH) is required for the development of a mature follicle, containing an egg capable of being fertilised.

It is responsible for final maturation and subsequent ovulation of the egg and maintains a hormone secreting body called the corpus luteum – formed at the site of egg expulsion – which provides support in the early stages of pregnancy.

Although FSH and LH are both necessary for egg maturation, only very small amounts of LH are needed. The minimal exposure to LH required for satisfactory egg maturation is called the LH Threshold. Too little LH, below a threshold level, can lead to inadequate maturation of eggs and can cause treatment to fail.

On the other hand, research has shown that excessive exposure to LH is damaging to egg maturation. The maximum exposure required for optimal egg maturation is called the LH Ceiling. 

There seems to be an Optimal Window for LH activity. The ‘LH Therapeutic Window’ needs to be precisely targeted, as too little or too much LH is damaging to the egg.


  To Top Of Page

© 2003-2008 Merck Serono S.A. -  Geneva. 
 Please read our Legal Statement.
US residents should consult the EMD Serono, Inc. fertility website at www.fertilitylifelines.com
Last Updated: 12/15/2008

Link to Serono Corporate Site